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Biphasic Pulmonary Blastoma Associated with                   
Cerebral Metastasis
ABSTRACT
enhanced tumor (11 cm in diameter) in the upper lobe of the left 
lung (Figure 1a). Cranial magnetic resonance imaging showed 
a mass on the frontal lobe (Figure 1B). although a histological 
diagnosis could not be obtained by transthoracic biopsy, 
image analyses led us to suspect it to be malignant. Firstly, the 
patient underwent cranial mass resection and then left upper 
lobectomy (Figure 2) and mediastinal lymph node dissection. 
Histological examination of the cranial lesion revealed a tumor 
that was composed of immature mesenchymal and epithelial 
elements (Figure 3a). Immunohistochemically, the epithelial 
component of the tumor was positive with epithelial membrane 
antigen (EMa) (Figure 3B), TTF-1 and focally CD-56. P63 and 
Cytokeratin 5/6 were negative. Based on these morphological 
and immunohistochemical features, the lesion was reported 
as metastatic biphasic pulmonary blastoma. After two 
weeks, lobectomy was performed and macroscopically, a 
necrotic mass, which was 10.5x9x5 cm in size, was noted. 
Histologically, a biphasic tumor with a mixture of primitive 
epithelial and mesenchymal components was seen (Figure 4). 
The epithelial component of the tumor was composed of well-
█    InTRODuCTIOn
Biphasic pulmonary Blastoma (BpB) is a very rare malignant 
lung tumor with an immature mesenchymal and epithelial 
component resembling fetal lung (1). In order to define po-
tential therapeutic targets in pulmonary blastoma. most of the 
authors have been reported to have a poor prognosis despite 
treatment (1, 5). 
We report a case of pulmonary blastoma that presented to and 
was treated at our unit and review their clinical, radiological, 
and pathological variability. 
█    CASE REPORT
A 68-year-old male presented with a pulmonary blastoma 
associated with a solitary cerebral metastasis. His medical 
history revealed a smoking history of 15 pack-years. The patient 
was admitted to our hospital with the chief complaints of head 
pain and chest pain on the left side. Computed tomography 
of the chest revealed a well-demarcated and heterogeneously 
Pulmonary blastoma is a very rare malignant tumor of the lungs. A biphasic pulmonary blastoma was histologically diagnosed by a 
characteristic finding as it was mainly constituted of immature tumor tissue that had both epithelial and mesenchymal components.  
We present a case of a 68-year-old man with biphasic pulmonary blastoma. The patient underwent cranial metastatectomy and left 
lung upper lobectomy. Although the tumor was resected, there was rapid metastasis to the cranial, liver, kidney and multiple bones. 
Although radiotherapy and chemotherapy were administrated, the patient died about 6 months postoperatively. Close follow-up 
and aggressive chemotherapy should be considered for such tumours. In the light of this case, the authors review the pathologic, 
clinical, radiological and therapeutic features of this very rare malignant lung tumor.      
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differentiated tubular glands that were lined by tall, columnar 
cells. The mesencyhmal component contained immature 
sarcomatous tumor tissue composed of small, oval to spindle 
cells. Immunohistochemically, EMa, aE1/aE3 and TTF-1 
were positive in the epithelial component, while vimentin was 
positive in the mesenchymal tumoral areas. 
figure 4: Histopathology of the lesion in the lung, showing 
pulmonary blastoma with a characteristic biphasic picture includes 
both immature carcinomatous tumor tissue as well-differentiated 
tubular glands and immature mesenchymal sarcomatous tumor 
tissue composed of small oval to spindle cells (Hematoxylin-Eosin 
x100).
figure 1: Computed 
tomography of the 
chest shows masses 
location in the upper 
lobe of the left 
lung (A), magnetic 
resonance imaging 
the head shows a 
mass on the frontal 
lobe (B).
figure 2: surgical specimen shows the mass in the left lung 
superior lobe.
figure 3: Histopathology of cranial lesion. Tumor consists of a 
spindle cell and malignant glandular component (Hematoxylin-
eosin x100) (A). The epithelial component is positive with EMa 
immunohistochemistry (EMA x100) (B). 
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Cranial recurrence was observed and re-resection was per-
formed two months after surgery, and radiation and che-
motherapy were administered. although he recovered well 
postoperatively, he died 6 months after surgery with multiple 
metastases to the bone and liver.
█    DISCuSSIOn
Pulmonary blastoma is an uncommon primary lung malignancy 
with a frequency of only 0.3-0.5% of all primary lung tumors 
(11, 13). Over 200 cases have been reported so far worldwide 
since the first description of the tumor by Barrett in 1945 (3).  
Pulmonary blastomas were designated ‘embryomas’ by 
Barnard in 1952 (2) and in 1961 spencer recategorised this 
neoplasm as a pulmonary blastoma (20). Many authors 
have reported monophasic pulmonary blastoma as the 
epithelial form, which is now called well-differentiated fetal 
adenocarcinoma, and the other form with only mesenchymal 
components was defined by Manivel et al. (5, 10, 15). Only 
the mesenchymal form called pleuropulmonary blastoma is 
observed in childhood (18). Pulmonary blastoma can therefore 
be classified into three groups: biphasic pulmonary blastoma 
(BpB), well-differentiated fetal adenocarcinoma (WDFa) and 
pleuropulmonary blastoma (PPB). However, according to the 
1999 classification of the World health Organization, WDFA 
and ppB are categorized as a variant of adenocarcinoma and 
soft tissue sarcoma of the lung (21).
Biphasic pulmonary blastoma is a subtype of these tumors, 
composed of immature epithelial and mesenchymal tissues, 
which may recapitulate early embryological lung development. 
Under the microscope, the globular component resembles 
immature bronchus and connective tissue as seen in the 
embryonic lung. BPB is more frequent in older people and 
in males and tends to affect adult ages. The etiology is still 
uncertain but there is strong evidence in the literature showing 
the correlation between cigarette smoking and PB (23). The 
types of p53 mutations are also similar to the p53 mutations 
found in other lung cancers (4).  Our patient had a history of 
smoking.
Immunohistochemical studies are useful in diagnosis BpB. 
Especially with a combination of both epithelial markers such 
as epithelial membrane antigen (EMA), Cytokeratin marker 
(CAM 5.2, CK 5/6), AE1/AE3, and a mesenchymal marker 
such as Vimentin, each component can be clearly highlighted 
from each other. CD-34 and S-100 protein stain both epithelial 
and mesenchymal components (16). also, Hansen et al 
reported novel marker as KIT (CD117) expression of BPB (6). 
In our patient, EMa, aE1/aE3 and TTF-1 were positive in 
the epithelial component, and vimentin was positive in the 
mesenchymal areas. Similarly with Hansen, we found CD117 
positivity in our tumor. CD56, P63, CK5/6, CD 34 and S100 
were negative. 
symptomatology varies from asymptomatic to symptoms of 
a non-specific pulmonary disease. Cough, hemoptysis, dys-
pnea, chest pain, respiratory distress, fever, anorexia and 
weight loss are the most common presenting features (1). 
In our patient, the head pain and chest pain were the major 
symptoms. 
Considerable immunoreactivity for alpha-fetoprotein (AFP) 
was reported in the literature (7). It was pointed out that the 
epithelial cells of pB might occasionally de-differentiate into 
cells functionally resembling fetal hepatic, foregut and yolk 
sac cells expressing AFP. Unfortunately AFP levels were not 
measured in our patient.
The most common roentgenologic pattern is a well-demarcat-
ed peripheral lesion, encapsulated by compression or atelec-
tatic lung tissue; although in some cases there is a tendency 
to lobulation and cavitation. Generally, the tumor has massive 
necrosis.  The size of the mass varies from a small peripheral 
nodule to a mass occupying the entire lobe or hemithorax (12, 
22). In our patient, the well-demarcated mass was shown on 
the cranial and chest images. 
The treatment of choice has been surgical excision, radiation 
and, in selected cases, a combination of chemotherapy with 
radiation (19). Adjunctive therapy is still controversial because 
of lack of data. The prognosis of this malignancy is poor; 
overall five-year survival is approximately 16 percent (8). Koss 
et al mentioned that the median survival was approximately 
one year (9). No correlation has been established between 
histopathologic criteria and survival. The factors that indicate 
poor prognosis are tumor recurrence, metastasis at initial 
presentation, tumor size over 5 cm and lymph node and 
distant organ metastasis. liver, central nervous system and 
bones are the most frequent location of distant metastases. 
Rapid progression has been reported despite radical resection 
(17). Our patient survival is 6 months due to distant multi-
organ metastasis. Macher-goeppinger s et al mentioned that 
detection of EGFR expression and mutation in PB suggests 
EGFR inhibition as a potential therapeutic option in the 
treatment of advanced PB. Moreover, the data confirm a 
crucial role of CTNNB1 mutations in the pathogenesis of PB, 
and indicate that CTNNB1 gene sequencing may be useful in 
distinguishing pB from other types of lung cancer (14).
Biphasic pulmonary blastomas are very rare tumors but can 
present with various clinical features and especially pathology 
diagnoses. Clinicians must be aware of the recurrence cere-
bral metastases despite the cranial metastatectomy.  Early de-
tection and treatment may improve prognosis. Further studies 
with more patients are needed to determine the characteris-
tics of the tumor.
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